GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Asset Impairment Charge

Rua Bioscience (NZSE:RUA) Asset Impairment Charge : NZ$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience Asset Impairment Charge?

Rua Bioscience's Asset Impairment Charge for the six months ended in Dec. 2024 was NZ$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was NZ$0.00 Mil.

Rua Bioscience Asset Impairment Charge Historical Data

The historical data trend for Rua Bioscience's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience Asset Impairment Charge Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Asset Impairment Charge
- - - -

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only - - - - -

Rua Bioscience Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00 Mil.

Rua Bioscience Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Rua Bioscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Asset Impairment Charge
Comparable Companies
ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904 BOM:532321
Traded in Other Exchanges
N/A
Address
1 Commerce Place, Awapuni, Gisborne, NZL, 4071
Website
https://www.ruabio.com
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany and New Zealand.

Rua Bioscience Headlines

No Headlines